Germline cancer genetics in precision medicine
Judy E. Garber, M.D., M.P.H.
Director, Center for Cancer Genetics
Professor of Medicine
Dana-Farber Cancer Institute
Dr. Garber conducts research in clinical cancer genetics, with a special focus in the genetics of breast cancer. She has played a major role in the development of national guidelines in cancer genetics. Dr. Garber is also a leader in research into the characteristics and treatment of triple negative or basal-like breast cancer, the most common form in women with BRCA1 mutations. Her translational research focuses on the evaluation of novel agents targeting DNA repair defects in breast cancer, including PARP inhibitors for treatment and prevention of breast cancer and other BRCA-associated cancers.
This page was last updated on Wednesday, August 11, 2021